Dermata Therapeutics, Inc. (DRMA)
Dermata Therapeutics, Inc. engages in the development and distribution of over-the-counter pharmaceutical dermatology-focused products in the United States. The company develops direct-to-consumer skincare products, including foundation treatment products for skin renewal and clearing treatment products for the treatment of acne under the Tome brand. Dermata Therapeutics, Inc. was incorporated in 2014 and is headquartered in San Diego, California.
Sector: Pharmaceutical Preparations
Industry: Biotechnology
Dermata Therapeutics, Inc.
NASDAQ:DRMAHealthcare · Biotechnology
-7.86%$0.7750
AH$0.7899+1.92%vs close
Mkt Cap$3.84M
Float3.02M
O/S4.96M
Vol
$ Vol
RVOL
Inst Own2.4%
SI2.6%
Earnings
Dilution
Financials Summary
Revenue$0
Net Income-$7.56M
Total Assets$7.86M
Free Cash Flow-$7.76M
Debt & Equity
Equity 100%
Total Debt$0
Total Equity$6.22M
Shares Outstanding
Short Interest
Split History3 splits · 3 reverse
2-year cumulative
1:10
Nasdaq bars a compliance period at 1:250
- 1:10Reverse splitAug 1, 202510 shares → 1
- 1:15Reverse splitMay 16, 202415 shares → 1
- 1:16Reverse splitMar 14, 202316 shares → 1
Balance Sheet Details
Assets$7.86M
Liabilities$1.64M
Accounts Receivable$0
Accounts Payable$461K
Inventory$0
PP&E (Net)$0
Goodwill$0
Intangible Assets$0
Income Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| YoY Growth | - | - | - | - | - | - | - |
| Cost of Revenue | $0 | $0 | $0 | $0 | $0 | $322 | $1K |
| Gross Profit | $0 | $0 | $0 | $0 | $0 | -$322 | -$1K |
| Gross Margin | - | - | - | - | - | - | - |
| Research and Development | $2.93M | $8.2M | $4.07M | $5.65M | $3.46M | $1.61M | $2.62M |
| Selling, General, and Administrative | $4.84M | $4.31M | $3.97M | $4.02M | $4.4M | $1.56M | $1.85M |
| Other | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Operating Expenses | $7.77M | $12.51M | $8.04M | $9.67M | $7.86M | $3.17M | $4.47M |
| Operating Income (EBIT) | -$7.77M | -$12.51M | -$8.04M | -$9.67M | -$7.86M | -$3.17M | -$4.47M |
| Operating Margin | - | - | - | - | - | - | - |
| Interest Expense | $0 | $0 | $0 | $0 | $46K | $197K | $251K |
| Interest Income | $215K | $226K | $247K | $64K | $46 | $197 | $0 |
| Other Income (Expense) | $215K | $226K | $247K | $64K | -$46K | -$64K | -$251K |
| Income Before Tax (EBT) | -$7.56M | -$12.29M | -$7.79M | -$9.61M | -$7.9M | -$3.24M | -$4.72M |
| Income Tax Expense | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Income | -$7.56M | -$12.29M | -$7.79M | -$9.61M | -$7.9M | -$3.24M | -$4.72M |
| Net Income Margin | - | - | - | - | - | - | - |
| Supplementary Data | |||||||
| EPS | -8.16 | -80.32 | -401.80 | -2088.00 | -152.70 | -932.64 | -95.50 |
| Diluted EPS | -8.16 | -80.32 | -399.81 | -2088.00 | -152.70 | -932.64 | -95.50 |
| Weighted Average OS | 926,192 | 153,000 | 19,400 | 4,604 | 52,053 | 3,470 | 3,470 |
| EBITDA | -$7.77M | -$12.29M | $247K | -$9.67M | -$7.86M | -$3.04M | -$4.47M |
| EBITDA Margin | - | - | - | - | - | - | - |
Balance Sheet
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Assets | |||||||
| Current Assets | |||||||
| Cash and Cash Equivalents | $7.52M | $3.16M | $7.44M | $6.24M | $10.8M | $530K | $1.99M |
| Short-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Cash and Short-Term Investments | $7.52M | $3.16M | $7.44M | $6.24M | $10.8M | $530K | $1.99M |
| Accounts Receivable | $0 | $0 | $8K | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | $54K | $13K | -$8K | $105K | $56K | $0 | $0 |
| Total Current Assets | $7.86M | $3.53M | $7.98M | $6.94M | $11.62M | $605K | $2.07M |
| Long-Term Assets | |||||||
| Property, Plant & Equipment Net | $0 | $0 | $0 | $0 | $0 | $0 | $322 |
| Goodwill | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Intangible Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Deferred Tax Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | -$0 |
| Total Long-Term Assets | $0 | $0 | $0 | $0 | $0 | $0 | $322 |
| Other Assets | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Assets | $7.86M | $3.53M | $7.98M | $6.94M | $11.62M | $605K | $2.07M |
| Liabilities | |||||||
| Current Liabilities | |||||||
| Accounts Payable | $461K | $808K | $866K | $497K | $515K | $104K | $337K |
| Short-Term Debt | $0 | $0 | $0 | $0 | $0 | $3.55M | $731K |
| Current Income Tax Payable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Current Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $979K | $0 | $716K | -$0 | $0 | $0 | $500K |
| Total Current Liabilities | $1.64M | $1.97M | $1.62M | $923K | $1.52M | $3.78M | $1.72M |
| Long-Term Liabilities | |||||||
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 | $0 | $553K |
| Long-Term Unearned Revenue | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Long-Term Deferred Tax Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Long-Term Liabilities | $0 | $0 | $0 | -$0 | -$0 | $0 | $0 |
| Total Long-Term Liabilities | $0 | $0 | $0 | -$0 | -$0 | $0 | $553K |
| Other Liabilities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities | $1.64M | $1.97M | $1.62M | $923K | $1.52M | $3.78M | $2.28M |
| Stockholders' Equity | |||||||
| Preferred Stock | $0 | $0 | $0 | $0 | $0 | $22.55M | $22.28M |
| Common Stock | $266 | $252 | $26 | $77 | $833 | $2.35M | $2.35M |
| Retained Earnings | -$73.23M | -$65.68M | -$53.39M | -$45.59M | -$35.98M | -$28.08M | -$24.84M |
| Comprehensive Income & Other | $0 | -$0 | $0 | $0 | $0 | $0 | -$0 |
| Other Stockholders' Equity | $79.46M | $67.24M | $59.74M | $51.61M | $46.09M | $22.55M | $22.28M |
| Total Equity | $6.22M | $1.56M | $6.36M | $6.02M | $10.11M | -$3.18M | -$210K |
| Minority Interest | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Total Liabilities and Equity | $7.86M | $3.53M | $7.98M | $6.94M | $11.62M | $605K | $2.07M |
| Supplementary Data | |||||||
| Total Debt | $0 | $0 | $0 | $0 | $0 | $3.55M | $1.28M |
| Net Debt | -$7.52M | -$3.16M | -$7.44M | -$6.24M | -$10.8M | $3.02M | -$708K |
Cash Flow Statement
| Period | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|---|
| Currency | USD | USD | USD | USD | USD | USD | USD |
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Operating Activities | |||||||
| Net Income | -$7.56M | -$12.29M | -$7.79M | -$9.61M | -$7.9M | -$3.24M | -$4.72M |
| Depreciation & Amortization | $0 | $0 | $8.04M | $0 | $0 | $322 | $1K |
| Deferred Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Stock-Based Compensation | $144K | $658K | $522K | $930K | $1.91M | $0 | $0 |
| Changes in Working Capital: | |||||||
| Accounts Receivable | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Accounts Payable | -$388K | -$109K | $369K | -$19K | $411K | -$233K | $122K |
| Other Working Capital | $45K | $575K | $494K | -$135K | -$121K | -$523K | -$197K |
| Total Working Capital Change | -$343K | $467K | $864K | -$154K | $290K | -$756K | -$75K |
| Other Non-Cash Items | $0 | $0 | -$8.04M | $0 | $14K | -$36K | $873K |
| Net Cash from Operating | -$7.76M | -$11.16M | -$6.41M | -$8.83M | -$5.69M | -$4.03M | -$3.92M |
| Investing Activities | |||||||
| Capital Expenditures | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Acquisitions | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Purchases of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Sales of Investments | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Investing Activities | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Cash from Investing | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Financing Activities | |||||||
| Debt Repaid | - | - | - | - | $556K | $810K | $776K |
| Common Stock Issuance | $12.17M | $6.89M | $7.61M | $4.28M | $15.39M | $0 | $0 |
| Common Stock Repurchases | -$367 | -$828 | -$40 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Other Financing Activities | -$50K | $1K | $187 | $287 | $0 | $0 | $0 |
| Net Cash from Financing | $12.12M | $6.89M | $7.61M | $4.28M | $15.96M | $2.57M | $4.73M |
| Forex Effect | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Net Change in Cash | $4.36M | -$4.28M | $1.2M | -$4.56M | $10.27M | -$1.46M | $812K |
| Supplementary Data | |||||||
| Operating Cash Flow | -$7.76M | -$11.16M | -$6.41M | -$8.83M | -$5.69M | -$4.03M | -$3.92M |
| Capital Expenditure | $0 | $0 | $0 | $4 | $0 | $0 | $0 |
| Free Cash Flow | -$7.76M | -$11.16M | -$6.41M | -$8.83M | -$5.69M | -$4.03M | -$3.92M |
| Cash at Beginning | $3.16M | $7.44M | $6.24M | $10.8M | $530K | $1.99M | $1.18M |
| Cash at End | $7.52M | $3.16M | $7.44M | $6.24M | $10.8M | $530K | $1.99M |